| Jason J Blomstedt, DO | |
|
1401 E H St, Mc Cook, NE 69001-3589 | |
| (308) 344-4110 | |
| (308) 344-8369 |
| Full Name | Jason J Blomstedt |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 1401 E H St, Mc Cook, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548351893 | NPI | - | NPPES |
| 47074801112 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 579 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Healthcare And Hospice | Mccook, NE | Home health agency |
| Community Health Care & Hospice | Mccook, NE | Hospice |
| Community Hospital | Mccook, NE | Hospital |
| The Nebraska Medical Center | Omaha, NE | Hospital |
| Decatur County Hospital | Oberlin, KS | Hospital |
| Tri Valley Health System | Cambridge, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mccook Clinic, P.c. | 0941196125 | 12 |
| Community Hospital Association | 9133101629 | 5 |
News Archive
A new study provides evidence to support a simple measurement for diagnosing clinically significant airflow obstruction, the key characteristic of chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States.
According to new results from a national survey, 19.9 percent of American adults in the United States (45.1 million) have experienced mental illness over the past year. The survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) indicates that 11 million adults (4.8 percent) in the U.S. suffered serious mental illness in the past year a diagnosable mental disorder has substantially interfered with, or limited one or more major life activities.
BARRX Medical, Inc. today announced the closing of a $15 million Series D financing, which was led by new investor Highland Capital Partners and joined by existing investors Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures, Greenspring Associates and others. BARRX Medical, Inc. develops endoscopic treatment solutions for treating precancerous lesions of the esophagus as well as other chronic gastrointestinal diseases.
Stroke is one of the leading causes of death and disability in the United States, but access to rapid EMS care and appropriate stroke care centers with the ability to deliver acute stroke therapies can drastically mitigate the debilitating effects of a stroke.
NanoBio Corporation has announced that it has seen promising results from an interim analysis of its phase 2 study of NB-002, a topical lotion for onychomycosis (nail fungus). Although the details remain confidential, the results clearly justify completing the study, according to NanoBio scientists
› Verified 5 days ago
| Entity Name | Mccook Clinic, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336290972 PECOS PAC ID: 0941196125 Enrollment ID: O20040225000128 |
News Archive
A new study provides evidence to support a simple measurement for diagnosing clinically significant airflow obstruction, the key characteristic of chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States.
According to new results from a national survey, 19.9 percent of American adults in the United States (45.1 million) have experienced mental illness over the past year. The survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) indicates that 11 million adults (4.8 percent) in the U.S. suffered serious mental illness in the past year a diagnosable mental disorder has substantially interfered with, or limited one or more major life activities.
BARRX Medical, Inc. today announced the closing of a $15 million Series D financing, which was led by new investor Highland Capital Partners and joined by existing investors Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures, Greenspring Associates and others. BARRX Medical, Inc. develops endoscopic treatment solutions for treating precancerous lesions of the esophagus as well as other chronic gastrointestinal diseases.
Stroke is one of the leading causes of death and disability in the United States, but access to rapid EMS care and appropriate stroke care centers with the ability to deliver acute stroke therapies can drastically mitigate the debilitating effects of a stroke.
NanoBio Corporation has announced that it has seen promising results from an interim analysis of its phase 2 study of NB-002, a topical lotion for onychomycosis (nail fungus). Although the details remain confidential, the results clearly justify completing the study, according to NanoBio scientists
› Verified 5 days ago
| Entity Name | Community Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588771158 PECOS PAC ID: 9133101629 Enrollment ID: O20040607001378 |
News Archive
A new study provides evidence to support a simple measurement for diagnosing clinically significant airflow obstruction, the key characteristic of chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States.
According to new results from a national survey, 19.9 percent of American adults in the United States (45.1 million) have experienced mental illness over the past year. The survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) indicates that 11 million adults (4.8 percent) in the U.S. suffered serious mental illness in the past year a diagnosable mental disorder has substantially interfered with, or limited one or more major life activities.
BARRX Medical, Inc. today announced the closing of a $15 million Series D financing, which was led by new investor Highland Capital Partners and joined by existing investors Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures, Greenspring Associates and others. BARRX Medical, Inc. develops endoscopic treatment solutions for treating precancerous lesions of the esophagus as well as other chronic gastrointestinal diseases.
Stroke is one of the leading causes of death and disability in the United States, but access to rapid EMS care and appropriate stroke care centers with the ability to deliver acute stroke therapies can drastically mitigate the debilitating effects of a stroke.
NanoBio Corporation has announced that it has seen promising results from an interim analysis of its phase 2 study of NB-002, a topical lotion for onychomycosis (nail fungus). Although the details remain confidential, the results clearly justify completing the study, according to NanoBio scientists
› Verified 5 days ago
| Entity Name | Community Hospital Association |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1841204500 PECOS PAC ID: 9133101629 Enrollment ID: O20100908000859 |
News Archive
A new study provides evidence to support a simple measurement for diagnosing clinically significant airflow obstruction, the key characteristic of chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States.
According to new results from a national survey, 19.9 percent of American adults in the United States (45.1 million) have experienced mental illness over the past year. The survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) indicates that 11 million adults (4.8 percent) in the U.S. suffered serious mental illness in the past year a diagnosable mental disorder has substantially interfered with, or limited one or more major life activities.
BARRX Medical, Inc. today announced the closing of a $15 million Series D financing, which was led by new investor Highland Capital Partners and joined by existing investors Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures, Greenspring Associates and others. BARRX Medical, Inc. develops endoscopic treatment solutions for treating precancerous lesions of the esophagus as well as other chronic gastrointestinal diseases.
Stroke is one of the leading causes of death and disability in the United States, but access to rapid EMS care and appropriate stroke care centers with the ability to deliver acute stroke therapies can drastically mitigate the debilitating effects of a stroke.
NanoBio Corporation has announced that it has seen promising results from an interim analysis of its phase 2 study of NB-002, a topical lotion for onychomycosis (nail fungus). Although the details remain confidential, the results clearly justify completing the study, according to NanoBio scientists
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason J Blomstedt, DO 1401 E H St, Po Box 1207, Mc Cook, NE 69001-3589 Ph: (308) 344-4110 | Jason J Blomstedt, DO 1401 E H St, Mc Cook, NE 69001-3589 Ph: (308) 344-4110 |
News Archive
A new study provides evidence to support a simple measurement for diagnosing clinically significant airflow obstruction, the key characteristic of chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States.
According to new results from a national survey, 19.9 percent of American adults in the United States (45.1 million) have experienced mental illness over the past year. The survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) indicates that 11 million adults (4.8 percent) in the U.S. suffered serious mental illness in the past year a diagnosable mental disorder has substantially interfered with, or limited one or more major life activities.
BARRX Medical, Inc. today announced the closing of a $15 million Series D financing, which was led by new investor Highland Capital Partners and joined by existing investors Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures, Greenspring Associates and others. BARRX Medical, Inc. develops endoscopic treatment solutions for treating precancerous lesions of the esophagus as well as other chronic gastrointestinal diseases.
Stroke is one of the leading causes of death and disability in the United States, but access to rapid EMS care and appropriate stroke care centers with the ability to deliver acute stroke therapies can drastically mitigate the debilitating effects of a stroke.
NanoBio Corporation has announced that it has seen promising results from an interim analysis of its phase 2 study of NB-002, a topical lotion for onychomycosis (nail fungus). Although the details remain confidential, the results clearly justify completing the study, according to NanoBio scientists
› Verified 5 days ago
Corinne Phillips-ward, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 E H St, Mc Cook, NE 69001 Phone: 308-344-4110 Fax: 308-344-8369 | |
John West, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 E H St, Mc Cook, NE 69001 Phone: 308-344-4110 Fax: 308-344-8369 | |
Kristin Marie Fulkerson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 E H St, Mc Cook, NE 69001 Phone: 308-344-4110 Fax: 308-344-8369 | |
Richard Klug, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1401 E H St, Mc Cook, NE 69001 Phone: 308-344-4110 Fax: 308-344-8369 | |
Dr. Hope Ann Ferguson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 E H St, Mc Cook, NE 69001 Phone: 308-344-8784 Fax: 308-344-8780 | |
Dr. Matthew Nielsen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 E H St, Mc Cook, NE 69001 Phone: 308-344-4110 |